You have 9 free searches left this month | for more free features.

Alkeran

Showing 26 - 50 of 187

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Hematologic Malignancy, Bone Marrow Transplant Trial in New York (Tocilizumab, Fludarabine, Melphalan)

Recruiting
  • Hematologic Malignancy
  • Bone Marrow Transplant
  • New York, New York
    Weill Cornell Medical College
Oct 27, 2021

Myeloma Trial in Little Rock (Melphalan, Velcade, Thalidomide)

Active, not recruiting
  • Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Dec 1, 2021

Myeloma Trial in Chicago (drug, procedure, device)

Active, not recruiting
  • Myeloma
  • Chicago, Illinois
    University of Chicago
Sep 14, 2021

Multiple Myeloma Trial in Berne (Melphalan, Bendamustine)

Completed
  • Multiple Myeloma
  • Berne, Switzerland
    Department for Medical Oncology University Hospital/Inselspital
Jul 29, 2021

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

MDS, Leukemia, Myeloid, Acute, Leukemia, Relapsed Adult Acute Myeloid Trial in New York (CPX-351, Fludarabine, Melphalan)

Active, not recruiting
  • Myelodysplastic Syndromes
  • +3 more
  • New York, New York
    Weill Cornell Medical College
Jan 26, 2022

Primary Systemic Amyloidosis, Light Chain Deposition Disease Trial in United States (drug, genetic, other, procedure)

Active, not recruiting
  • Primary Systemic Amyloidosis
  • Light Chain Deposition Disease
  • Denver, Colorado
  • +6 more
Aug 24, 2022

Recurrent Adult Hodgkin Lymphoma Trial in Duarte (biological, drug, other, procedure)

Active, not recruiting
  • Recurrent Adult Hodgkin Lymphoma
  • basiliximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Multiple Myeloma Trial in Little Rock (Velcade, Melphalan, Thalidomide)

Active, not recruiting
  • Multiple Myeloma
  • Little Rock, Arkansas
    University of Arkansas for Medical Sciences
Sep 7, 2021

Leukemia, MDS, Childhood Acute Myeloid Leukemia in Remission Trial in Minneapolis (biological, drug, procedure)

Recruiting
  • Leukemia
  • +12 more
  • filgrastim
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 20, 2022

Adult Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Arising From Previous Myelodysplastic Syndrome, Adult

Active, not recruiting
  • Adult Acute Lymphoblastic Leukemia in Remission
  • +6 more
  • Duarte, California
    City of Hope Medical Center
Feb 17, 2022

Multiple Myeloma Trial in Maywood (Carfilzomib, Busulfan IV, Melphalan IV)

Recruiting
  • Multiple Myeloma
  • Maywood, Illinois
    Loyola University Medical Center
Apr 23, 2021

Lymphoma, HIV Trial in United States (Autologous transplant, BCNU, Etoposide)

Completed
  • Lymphoma
  • HIV
  • Autologous transplant
  • +4 more
  • Duarte, California
  • +15 more
Dec 6, 2022

GVHD, Leukemia, Lymphoma Trial in Duarte (biological, drug, procedure, radiation, other)

Active, not recruiting
  • Graft Versus Host Disease
  • +2 more
  • rituximab
  • +8 more
  • Duarte, California
    City of Hope Medical Center
Mar 17, 2022

Multiple Myeloma Trial in Canada (Busulfan, Melphalan, Lenalidomide)

Completed
  • Multiple Myeloma
  • Edmonton, Alberta, Canada
  • +9 more
Sep 20, 2022

Previously Treated Myelodysplastic Syndrome, Recurrent Adult Acute Lymphoblastic Leukemia, Recurrent Adult Acute Myeloid

Recruiting
  • Previously Treated Myelodysplastic Syndrome
  • +3 more
  • Fludarabine Phosphate
  • +9 more
  • Chicago, Illinois
    University of Chicago Comprehensive Cancer Center
Jan 7, 2022

Autologous Hematopoietic Stem Cell Transplant Recipient, Loss of Chromosome 17p, Plasma Cell Leukemia Trial in Duarte (drug,

Active, not recruiting
  • Autologous Hematopoietic Stem Cell Transplant Recipient
  • +4 more
  • Duarte, California
    City of Hope
Mar 17, 2022

GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

Recruiting
  • GVHD
  • +15 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Sep 30, 2021

Chronic Myeloid Leukemia Trial in Austria, Czechia, Italy (Fludarabine, Thiotepa, Melphalan)

Completed
  • Chronic Myeloid Leukemia
  • Graz, Austria
  • +3 more
Apr 14, 2021

Acute Lymphoblastic Leukemia (ALL), Acute Myeloid Leukemia (AML), MDS (MDS) Trial in Memphis (drug, biological, device)

Recruiting
  • Acute Lymphoblastic Leukemia (ALL)
  • +7 more
  • Memphis, Tennessee
    St. Jude Children's Research Hospital
Oct 8, 2021

Multiple Myeloma Trial in United States (procedure, drug, biological)

Completed
  • Multiple Myeloma
  • Tumor Cell Collection
  • +6 more
  • San Francisco, California
  • +14 more
Jul 11, 2022

Retinoblastoma Trial in France (Melphalan or Melphalan + Topotecan, etoposide, carboplatin and vincristine, Carboplatin

Recruiting
  • Retinoblastoma
  • Melphalan or Melphalan + Topotecan
  • +6 more
  • Saint-Denis, La Réunion, France
  • +27 more
Nov 24, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Multiple Myeloma Trial in Baltimore (biological, drug, procedure)

Completed
  • Multiple Myeloma
  • Activated marrow infiltrating lymphocytes
  • +6 more
  • Baltimore, Maryland
    Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Mar 16, 2021

Acute Myeloid Leukemia in Remission, MDS, Chronic Myeloid Leukemia in Remission Trial in Belgium (Thymoglobulin, Melphalan,

Recruiting
  • Acute Myeloid Leukemia in Remission
  • +9 more
  • Antwerp, Belgium
  • +9 more
Oct 5, 2021